146 related articles for article (PubMed ID: 37579543)
1. Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer.
Kwon JJY; Liu AQ; Milner TD; Prisman E
Oral Oncol; 2023 Nov; 146():106537. PubMed ID: 37579543
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
3. Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
Mehta MP; Prince R; Butt Z; Maxwell BE; Carnes BN; Patel UA; Stepan KO; Mittal BB; Samant S
Head Neck; 2021 Dec; 43(12):3955-3965. PubMed ID: 34617643
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
[TBL] [Abstract][Full Text] [Related]
5. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
[TBL] [Abstract][Full Text] [Related]
6. Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy.
Scott SI; Madsen AKØ; Rubek N; Charabi BW; Wessel I; Jensen CV; Friborg J; von Buchwald C
Laryngoscope; 2023 Aug; 133(8):1893-1898. PubMed ID: 36239625
[TBL] [Abstract][Full Text] [Related]
7. Avoidance of primary site adjuvant radiotherapy following transoral robotic surgery: a cohort study.
Fradet L; Charters E; Gao K; Froggatt C; Palme C; Riffat F; Nguyen K; Wu R; Milross C; Clark JR
ANZ J Surg; 2022 Mar; 92(3):511-517. PubMed ID: 35018703
[TBL] [Abstract][Full Text] [Related]
8. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
[TBL] [Abstract][Full Text] [Related]
9. Comment on "Decisional regret, symptom burden, and quality of life following transoral robotic surgery for oropharyngeal cancer".
Silva Cunha JL
Oral Oncol; 2023 Dec; 147():106626. PubMed ID: 37951117
[No Abstract] [Full Text] [Related]
10. Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up.
Lee E; Gorelik D; Crowder HR; Badger C; Schottler J; Li NW; Siegel R; Sadeghi N; Goodman JF; Thakkar PG; Joshi AS
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):298-304. PubMed ID: 34752157
[TBL] [Abstract][Full Text] [Related]
11. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
[TBL] [Abstract][Full Text] [Related]
12. Swallowing and communication outcomes following primary transoral robotic surgery.
Charters E; Wu R; Milross C; Bogaardt H; Freeman-Sanderson A; Ballard K; Davies S; Oates J; Clark J
Head Neck; 2021 Jul; 43(7):2013-2023. PubMed ID: 33687115
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Free Flap Reconstruction Following Salvage Robotic-Assisted Resection of Recurrent and Residual Oropharyngeal Cancer in 3 Patients.
Williamson A; Haywood M; Awad Z
Ear Nose Throat J; 2021 Dec; 100(10_suppl):1113S-1118S. PubMed ID: 32608257
[TBL] [Abstract][Full Text] [Related]
14. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD;
Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990
[TBL] [Abstract][Full Text] [Related]
15. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R
Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176
[TBL] [Abstract][Full Text] [Related]
16. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer.
Scott SI; Kathrine Ø Madsen A; Rubek N; Charabi BW; Wessel I; Fredslund Hadjú S; Jensen CV; Stephen S; Patterson JM; Friborg J; Hutcheson KA; Kehlet H; von Buchwald C
Cancer Med; 2021 Jan; 10(2):483-495. PubMed ID: 33277795
[TBL] [Abstract][Full Text] [Related]
17. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.
Dziegielewski PT; Teknos TN; Durmus K; Old M; Agrawal A; Kakarala K; Marcinow A; Ozer E
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1099-108. PubMed ID: 23576186
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery: A 1-year follow-up study.
Mercante G; Masiello A; Sperduti I; Cristalli G; Pellini R; Spriano G
J Craniomaxillofac Surg; 2015 Oct; 43(8):1561-6. PubMed ID: 26197796
[TBL] [Abstract][Full Text] [Related]
19. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
[TBL] [Abstract][Full Text] [Related]
20. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors.
Goepfert RP; Fuller CD; Gunn GB; Hanna EY; Lewin JS; Zaveri JS; Hubbard RM; Barrow MP; Hutcheson KA
Head Neck; 2017 Nov; 39(11):2151-2158. PubMed ID: 28736965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
